Advertisement
UK markets close in 7 hours 57 minutes
  • FTSE 100

    7,842.90
    -34.15 (-0.43%)
     
  • FTSE 250

    19,316.79
    -133.88 (-0.69%)
     
  • AIM

    741.83
    -3.46 (-0.46%)
     
  • GBP/EUR

    1.1678
    -0.0006 (-0.05%)
     
  • GBP/USD

    1.2437
    -0.0001 (-0.01%)
     
  • Bitcoin GBP

    51,755.00
    +2,688.95 (+5.48%)
     
  • CMC Crypto 200

    1,327.64
    +15.01 (+1.15%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CRUDE OIL

    83.70
    +0.97 (+1.17%)
     
  • GOLD FUTURES

    2,404.20
    +6.20 (+0.26%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,231.54
    -154.33 (-0.94%)
     
  • DAX

    17,667.29
    -170.11 (-0.95%)
     
  • CAC 40

    7,970.06
    -53.20 (-0.66%)
     

Why Morphic Holding Stock Is Skyrocketing Today

Why Morphic Holding Stock Is Skyrocketing Today

More important than its financial results, the biopharmaceutical company announced results from a clinical trial and other developments regarding collaboration agreements with big-name drugmakers. Morphic Holding reported interim data from a phase 1 clinical trial for MORF-057, a potential medicine for inflammatory bowel disease (IBD).